Immuneering Corp Net Asset Momentum
Immuneering Corp net asset momentum. Immuneering Corp (IMRX) recorded a net asset momentum of -54.3% as of December 2024, with net assets of $41.39 Million USD. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. Explore Immuneering Corp cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
YoY Momentum
Current Net Assets
Years of Data
Country
Net Asset Momentum of Immuneering Corp (2019–2024)
Net asset momentum of Immuneering Corp from 2019 to 2024. This chart tracks Immuneering Corp's year-over-year net asset growth across 6 annual reporting periods from 2019 to 2024. The most recent momentum reading is -54.3%, with net assets of $41.39 Million USD as of December 2024. See IMRX net assets for net asset value and shareholders' equity analysis.
Immuneering Corp Net Asset Momentum by Year (2019–2024)
Immuneering Corp net asset momentum by year from 2019 to 2024. The table below shows the complete annual net asset history for Immuneering Corp from 2019 to 2024, covering 6 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and overall valuation, see market cap of Immuneering Corp.
| Year | Net Assets (USD) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2024 | $41.39 Million | $52.71 Million | $11.33 Million | ▼ -54.3% |
| 2023 | $90.58 Million | $102.58 Million | $12.01 Million | ▼ -17.5% |
| 2022 | $109.85 Million | $122.37 Million | $12.52 Million | ▼ -29.6% |
| 2021 | $155.98 Million | $166.70 Million | $10.72 Million | ▲ +793.8% |
| 2020 | $-22.48 Million | $38.42 Million | $60.90 Million | ▼ -244.4% |
| 2019 | $-6.53 Million | $14.10 Million | $20.63 Million | — |